Who owns the audience when brand, media, and sales all target the same physician?
Host Matt Nam sits down live with Glenniss Richards, Senior Director of Digital Media at Bayer, and Greg Palko, Franchise Head, North America Hematology-Oncology at Kyowa Kirin, to discuss how pharma brand, media, and sales teams share one audience, and where AI should and should not contribute
For pharmaceutical companies, aligning brand, digital media, and field sales teams around a shared healthcare provider (HCP) audience remains a persistent challenge. Add AI, increasingly complex data ecosystems, and the demands of rare disease marketing, and the stakes become even higher.
In this live episode of HealthLink Signals, Glenniss Richards of Bayer and Greg Palko of Kyowa Kirin join HealthLink Dimensions to explore what it really takes to connect teams, data, and technology to create more coordinated, effective HCP engagement.
Drawing on their leadership experience across pharmaceutical digital media, oncology, and rare disease, Richards and Palko challenge conventional thinking about audience ownership, data-driven field strategies, and the role of AI in healthcare marketing. They also tackle a critical question facing pharmaceutical organizations: Are companies investing in the right technology before getting their audience strategy right?
Watch the conversation to explore:
Better data, smarter technology, or stronger human connections? Hear how two pharmaceutical industry leaders are navigating these competing priorities and what their experiences reveal about the future of HCP engagement.
Watch Episode Ten of HealthLink Signals to hear the full conversation.